I’m glad to be wrong on this! Great news.

2 Likes

I am sure labs will vary, however.

My problem is I would like to target around 0.025 mmol/L

1 Like

Can you just find the dose that gets you to .06 and then halve it?

It sadly does not work exactly that way. However, you can get to a dose that is measurable and reduce it and just live with the fact that it won’t be simply linear.

Yah i know it wont be exactly linear but at least its not exponential right?

Difficult to say what it is.

However, I think it is reasonable to assume if you reduce the daily dosage that the serum level will stabilise at a lower level. A first approximation of linear is reasonable, but it is probably linear with a constant rather than linear with a zero constant.

2 Likes

Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial 2024

In this RCT, therapy with lithium aspartate, 10 to 15 mg/d, was ineffective for treating PCC fatigue and cognitive dysfunction. Another RCT is required to assess the potential benefits of higher lithium dosages for treating neurologic PCC.

2 Likes

By how much? Any way to gauge the % of increased effect? 20%? 50%?

TLDR: A guest on Matt Kaberlein’s podcast claims that lithium may significantly reduce blood-test-measured Tau levels in people with elevated Tau.

In the most recent Matt Kaberlein podcast, he interviewed Jon Berner, a licensed psychiatrist who appears to work with people with dementia or who are worried about dementia.

He prescribes lithium - unclear how much - and says he believes that the evidence is strong for lithium for life extension in humans.

Has also uses a test that combines tau, nfl, and amyloid to gauge if someone is in the early stages of dementia - all three for Alzheimers or just elevated tau for Lewy Body).

The numbers: he has 150 patients. He says 30% of them - so 45 or so - were outside of the normal range for tau, which would put them in the top 5 percentile. For those patients, he claims that lithium brings down their Tau test results by over 50%. He plans on presenting his data at the upcoming GSA conference.

He is really cagey about dosing and wouldn’t give any clues about how much he uses except to say that when we prescribed 900mg for bipolar disorder in the past it was way too much. He did mention that the Brazilian study on people with MCI used 600mg and that was way too high and resulted in side effects.

11 Likes

I listened to it too. Very compelling but just wouldn’t give any ballpark dosage, like you said. Really was hoping to at least get a clue for how much to take.

1 Like

As always, we know too little. Is lithium life or health extending for most, or only for those who due to their vulnerabilities can benefit. Example: for years studies of aspirin and colon cancer were contradictory. Transpired that a percentage (about 25%?) of people have a specific genetic variant resulting in vulnerability to CC, and that particular variant vulnerability is helped by aspirin. The rest, who don’t have it, or who have a different genetic CC vulnerablility are not helped by aspirin, and can even sustain gastric injury. Lithium, tau, flau, blau and shlau, do you need it, or is it actually negative for you, as with aspirin that doesn’t fix your issue, but because of side effects, is a net negative. Depending on dose lithium too has sides, such as kidney damage as one example. But to someone who benefits, aspirin, lithium, X, seems like a miracle and they can personally attest to its benefits, spread the word far and wide, and recommend to all… which can damage and not benefit “all”.

That’s the trouble when you study/focus on one modality. It is easy to get tunnel vision, overvalue and lose the broader perspective. If you study a hammer for long, you might think that everything is a nail. So when I listen to someone who evangelizes a single agent, like lithium, I wonder about the broader context.

How exactly does lithium fit into longevity overall? I have no idea. None. With rapa, at least I have hints. With lithium, I have confusion. SGLT2i inhibitors might extend life/health (canagliflozin, ITP, mice). But SGLT2i massively get rid of lithium in the urine; they deplete lithium from your body. Yet, SGLT2i are a big health and life(?) boon. Does part of the benefit derive from low lithium and so supplementing becomes counterproductive, or does it work in spite of litium depletion, and therefore if on SGLT2i, you should supplement even more to compensate. I have no idea.

The podcast, as happens often in the longevity space, left me with more questions than answers. Result: frustration insofar as “what do I do with this” - is anything actionable here or another “interesting” intellectual exercise and more rabbit holes which I already have plenty of to last me several lifetimes; what I sadly don’t have is several lifetimes. Oh, goody, another rabbit hole… so?

2 Likes

I have explained my view on lithium gsk3

1 Like

I believe that SGLT2I and lithium are both beneficial for longevity. So, I take both, but I take additional lithium to compensate for the effects of the SGLT2I.

Dr. Attia took up to 60 mg of lithium and he said that was pushing the edge and needed to monitor his blood levels. I am taking 10 mg, but 70% of that is going in my urine due to the SGLT2I. 5 mg seems to be the sweet spot for me IMHO.

2 Likes

Was. it rhis episode?

4 Likes

5mg is the amount I’m on as well, and I also take SGLT2 and Telmisartan. I have no idea if I’m on the right amount or not. Lots of different perspectives here.

3 Likes

Apologies if covered already but newly interested in microdosing lithium. in terms of dosing. Higher water concentration is associated with longevity and:
“Lithium is commonly found in drinking water and various foods, with dietary intake estimated at 0.6 to 3.1 milligrams per day in the United States in 1985 (Schrauzer, 2002)”

"Safety: Doses below 5 mg/day are considered safe, but high doses are associated with toxicity, such as kidney damage. "

from

and

4 Likes

Does anyone have a link to the complete Jon Berner podcast. The YouTube version cuts off the beginning and a bunch more at the end. I could not find the podcast on optispan at all

I listened to it on spotify yesterday.

1 Like

I just found it on Spotify. It starts abruptly with Kaeberlein asking Berner how he became interested in Rapamycin. I did not listen through to the end because Spotify does not have a download or fast forward feature afaik. I suspect this is the same audio as the YouTube and Listennotes version. It seems like it is missing part of the interview at the beginning and end, but perhaps that is just how it is.

2 Likes

The second half of this Jon Berner podcast is now available. The topic is Rapamycin plus Ketamine, and the need for regulatory reform in Washington State.

1 Like